Kisspeptin-10 Peptide: An exploration of its potential

Kisspeptins, a family of compounds encoded by the KISS1 gene, have garnered significant interest in the scientific community due to their intriguing potential in various physiological processes. Among these, Kisspeptin-10, a decapeptide derived from the cleavage of the primary kisspeptin precursor, has emerged as a particularly notable molecule.

This article explores the potential functions and mechanisms of Kisspeptin-10 in biological systems, emphasising its hypothesised influence in reproductive physiology, metabolic regulation, and tumor suppression.

Kisspeptin-10, consisting of ten amino acids, is the shortest active form of the kisspeptins. Studies suggest that its structure allows it to bind effectively to the G-protein coupled receptor GPR54 (also known as KISS1R).

This receptor-ligand interaction is crucial for the peptide’s biological activity.

Research indicates that the binding of Kisspeptin-10 to GPR54 may trigger a cascade of intracellular signalling pathways, primarily involving phospholipase C and the subsequent release of inositol triphosphate and diacylglycerol. These events may lead to an influence in intracellular calcium levels and the activation of protein kinase C, which are critical for the downstream impacts observed in various tissues.

One of the most extensively studied potential roles of Kisspeptin-10 is in regulating the hypothalamic-pituitary-gonadal (HPG) axis. It is hypothesised that Kisspeptin-10 might act as a potent stimulator of gonadotropin-releasing hormone (GnRH) secretion.

This, in turn, may influence the secretion of luteinising hormone (LH) and follicle-stimulating hormone (FSH) from the anterior pituitary gland. These hormones are pivotal for regulating gonadal function, including steroid and gametogenesis.

 Investigations purport that Kisspeptin-10 might play a critical role in the onset of puberty. It has been theorized that the increased expression of Kisspeptin and its receptor during this developmental stage might be a key trigger for the reactivation of the HPG axis, leading to the maturation of the reproductive system.

Moreover, Kisspeptin-10 is believed to regulate reproductive processes, potentially modulating the frequency and amplitude of GnRH pulses.

Beyond its reproductive functions, Kisspeptin-10 is also speculated to significantly affect metabolic processes. A growing body of data suggests that kisspeptins might be involved in regulating energy homeostasis.

Kisspeptin-10 is expressed in several regions of the brain that are known to be critical for metabolic control, including the hypothalamus. It is hypothesised that Kisspeptin-10 might influence appetite and food intake by interacting with other neuropeptides and hormones involved in energy balance, such as leptin and insulin.

Furthermore, studies suggest that Kisspeptin-10 might play a role in glucose homeostasis. Preliminary research indicates that Kisspeptin-10 might increase insulin secretion from pancreatic β-cells and improve insulin sensitivity in peripheral tissues.

These properties suggest that Kisspeptin-10 might have potential implications for managing metabolic disorders, such as obesity and type 2 diabetes, although more extensive studies are needed to fully understand these mechanisms.

Another intriguing aspect of Kisspeptin-10 is its potential role in tumor suppression. The KISS1 gene was initially identified as a metastasis suppressor gene in melanoma cells. Subsequent research has indicated that Kisspeptin-10 and its receptor might inhibit the metastatic spread of various cancers, including breast, prostate, and gastric.

It is hypothesised that Kisspeptin-10’s anti-tumorigenic properties might be mediated through several mechanisms. For instance, Kisspeptin-10 is believed to cease cell migration and invasion by modulating the expression of matrix metalloproteinases (MMPs), enzymes that affect the extracellular matrix and facilitate tumor metastasis. Kisspeptin-10 might induce apoptosis and inhibit angiogenesis, contributing to its potential anti-cancer potential.

Emerging data suggests that Kisspeptin-10 might also have protective parts in the cardiovascular and nervous systems. In the cardiovascular context, Kisspeptin-10 is expressed in the heart and blood vessels and is theorized to influence vascular tone and blood pressure regulation.

Studies suggest that Kisspeptin-10 might have vasoconstrictive impacts, which might be mediated through its interaction with the endothelial cells lining the blood vessels.

In the nervous system, Kisspeptin-10 is believed to exert neuroprotective impacts. It is hypothesised that Kisspeptin-10 might protect neurons from excitotoxic damage and oxidative stress, potentially by activating survival pathways such as the PI3K/Akt pathway. These properties might have implications in the context of neurodegenerative disorders, although further research is needed to elucidate the exact mechanisms involved.

Investigations purport that Kisspeptin-10 is a multifaceted peptide with a wide range of potential biological functions. Its possible roles in reproductive physiology, metabolic regulation, tumor suppression, cardiovascular function, and neuroprotection highlight its importance in maintaining organismal homeostasis.

While significant progress has been made in understanding the mechanisms of Kisspeptin-10, many aspects of its functions and implications remain speculative and warrant further investigation. As research continues to uncover the complexities of this peptide, it may pave the way for novel strategies in various fields.

Please remember that none of the compounds mentioned in this paper have been approved for human or animal consumption.

[i] Navarro VM. Metabolic regulation of kisspeptin – the link between energy balance and reproduction. Nat Rev Endocrinol. 2020 Aug;16(8):407-420. doi: 10.1038/s41574-020-0363-7. Epub 2020 May 19. PMID: 32427949; PMCID: PMC8852368.

[ii] Izzi-Engbeaya C, Hill TG, Bowe JE. Kisspeptin and Glucose Homeostasis. Semin Reprod Med. 2019 May;37(3):141-146. doi: 10.1055/s-0039-3400242. Epub 2019 Dec 23. PMID: 31869842.

[iii] Tsoutsouki J, Patel B, Comninos AN, Dhillo WS, Abbara A. Kisspeptin in the Prediction of Pregnancy Complications. Front Endocrinol (Lausanne). 2022 Jul 19;13:942664. doi: 10.3389/fendo.2022.942664. PMID: 35928889; PMCID: PMC9344876.

[iv] Mills EGA, O’Byrne KT, Comninos AN. Kisspeptin as a Behavioral Hormone. Semin Reprod Med. 2019 Mar;37(2):56-63. doi: 10.1055/s-0039-3400239. Epub 2019 Dec 17. PMID: 31847025.